Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
IND application for EB-003 expected in early 2026
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Subscribe To Our Newsletter & Stay Updated
